This document discusses techniques for recanalizing chronic total occlusions (CTOs). It defines a CTO and explains their etiology. Successful recanalization is associated with improved angina and reduced ischemia. Key steps include careful pre-procedure planning, selecting appropriate guidewires and microcatheters, and using techniques like parallel wiring or penetration when standard wiring fails. Expertise is important for high success rates. Proper wire shaping and handling can help avoid subintimal tracking.
Coronary CTO is characterized by heavy atherosclerotic plaque burden within the artery, resulting in complete (or nearly complete) occlusion of the vessel. Although the duration of the occlusion is difficult to determine on clinical grounds, a total occlusion must be present for at least 3 months to be considered a true CTO. Patients with CTO typically have collateralization of the distal vessel on coronary angiography, but these collaterals may not provide sufficient blood flow to the myocardial bed, resulting in ischemia and anginal symptoms. CTO is clinically distinct from acute coronary occlusion, which occurs in the setting of ST-segment–elevation myocardial infarction, or subacute coronary occlusion, discovered with delayed presentation after ST-segment–elevation myocardial infarction. Clinical features and treatment considerations of these entities differ considerably from CTO.
Among patients who have a clinical indication for coronary angiography, the incidence of CTO has been reported to be as high as 15% to 30%. Patients with CTO are referred for angiography because of anginal symptoms or significant ischemia on noninvasive ischemia testing. Patients who are symptomatic will have stable exertional angina resulting from a limitation of collateral vessel flow to meet myocardial oxygen demand with stress. Of patients referred for PCI in clinical trials of CTO PCI, only 10% to 15% of patients are asymptomatic. It is likewise uncommon for patients with CTO to present with an acute coronary syndrome caused by the CTO itself.
This document provides an overview of approaches to chronic total occlusion percutaneous coronary intervention (CTO PCI). It defines CTOs and discusses their prevalence. Key points include:
- Success rates for CTO PCI are over 90% currently due to improved techniques and tools.
- Imaging like angiography, CT angiography, and IVUS help plan procedures by assessing lesion characteristics and collateral circulation.
- The retrograde approach and antegrade dissection and re-entry are common techniques in addition to the standard antegrade wire escalation method.
- Scoring systems like the J-CTO and W-CTO scores can predict difficulty and likelihood of success to help determine approach.
- Careful planning including
Distal balloon occlusion devices and distal filter devices are the main types of embolic protection devices (EPDs) used during percutaneous coronary intervention (PCI). Distal balloon occlusion devices use a balloon to occlude blood flow distal to the lesion during PCI, while distal filter devices use a nitinol mesh filter to capture debris without interrupting blood flow. Major trials have shown the benefits of EPDs for saphenous vein graft interventions and for STEMI patients undergoing PCI. EPD selection depends on lesion location and vessel characteristics. EPDs are recommended for saphenous vein graft PCI but their routine use is not supported for native coronary artery PCI.
Strategies of handling side branch during pciManjunath D
This document summarizes strategies for handling side branches during percutaneous coronary interventions (PCI) involving coronary bifurcations. It discusses:
1. Bifurcation lesions account for 15-20% of PCIs and have lower success rates and higher restenosis than other PCIs.
2. Classification systems for bifurcation lesions including the Medina and Duke classifications.
3. Techniques for stenting bifurcation lesions including provisional stenting, T-stenting, crush techniques, and double stenting.
4. Randomized trials have found that provisional stenting is generally as effective as more complex double stenting techniques for treating bifurcation lesions.
Session 3 - Microcatheters, new developmentsEuro CTO Club
This document discusses recent developments in microcatheter technology, including new microcatheters from Asahi such as the Corsair Pro XS. It describes design features of various microcatheters like tapered shafts, braided coils, and tip configurations. New devices aim to improve trackability, torque response, and crossability. While microcatheter technology facilitates endovascular techniques, the document notes that further coordinated evolution is still needed between microcatheters and guidewires.
This document summarizes the history and development of bioresorbable scaffolds and stents. It discusses early technologies like balloon angioplasty and bare metal stents, followed by drug-eluting stents. It then focuses on bioresorbable polymer and metal scaffolds/stents, including the Absorb BVS, Igaki-Tamai stent, DREAMS stents, and REVA stent. Clinical trials evaluating various bioresorbable devices are summarized, showing improvements in reducing restenosis but also issues with vessel recoil and neo-intimal hyperplasia.
This document discusses intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for assessing coronary artery disease and optimizing percutaneous coronary interventions. It provides an overview of the basic principles, equipment, and clinical applications of IVUS and OCT. IVUS and OCT produce high-resolution cross-sectional images of coronary arteries, allowing for more accurate evaluation of vessel size, plaque morphology, and stent results compared to angiography alone. Both modalities can help answer questions that arise during interventional cardiology procedures. Patients with complex coronary disease may especially benefit from an approach that incorporates intravascular imaging.
This document discusses strategies and techniques for managing chronic total occlusions (CTO). CTOs are coronary blockages that are completely blocked for more than 3 months. The document outlines the histopathology of CTOs and factors that predict success or failure of percutaneous coronary intervention (PCI). It also describes various guidewires, microcatheters, and crossing devices that can be used to recanalize CTOs via antegrade or retrograde approaches. Successful PCI of CTOs has been shown to improve angina, reduce the need for bypass surgery, and improve survival.
This document discusses chronic total occlusion (CTO) of coronary arteries. It defines CTO and differentiates it from functional occlusions and pseudo-occlusions. The prevalence of CTO is estimated to be around 15% based on registry data. CTOs present technical challenges for percutaneous coronary intervention (PCI) due to factors like lesion length, calcification, and tortuosity. Proper preparation is important for CTO PCI, including adequate guide support and anticoagulation. Scoring systems can help predict the difficulty of crossing a CTO. Special guidewires and techniques may be needed depending on the lesion characteristics and collateral pathways.
The document summarizes various strategies for managing thrombus burden during primary angioplasty for myocardial infarction. It discusses thrombus grading scales, the composition and types of thrombus, and the role of medications like GP IIb/IIIa inhibitors (abciximab, tirofiban, eptifibatide), heparin, and bivalirudin. It also compares intracoronary versus intravenous administration of these drugs and evaluates trials comparing different treatment strategies. Mechanical thrombectomy devices and a combined pharmacologic and mechanical approach are also reviewed.
Stent thrombosis is a rare but serious complication of percutaneous coronary intervention (PCI) with mortality rates between 25-40%. It is classified based on timing (acute, subacute, late, very late) and etiology (primary, secondary). Risk factors include premature discontinuation of dual antiplatelet therapy, smoking, diabetes, chronic kidney disease, acute coronary syndrome, and high platelet reactivity. Strategies to minimize stent thrombosis involve careful patient selection, optimal stent deployment, adherence to potent dual antiplatelet regimens, and treatment involving emergent thrombectomy with escalated antiplatelet therapy.
The document discusses approaches to bifurcation lesions in coronary arteries. It defines a bifurcation lesion as a lesion located at the bifurcation of a main branch and side branch. Some key points discussed include:
- Provisional stenting of the main branch with adjunctive treatment of the side branch is generally the preferred initial approach.
- Double stenting techniques like culotte stenting and crush stenting are more complex but may be needed for large side branches or complex lesions.
- Factors like side branch size, angle of bifurcation, and extent of disease impact treatment decisions between single versus double stenting.
- Techniques for wiring the side branch, optimizing stent placement, and treating
The document discusses various stenting strategies for treating coronary bifurcation lesions, including newer advancements. It summarizes findings on stent thrombosis and major adverse cardiac event rates from randomized trials comparing one-stent versus two-stent approaches. It also outlines techniques for provisional stenting, elective double stenting, crush and sleeve methods, and left main coronary artery bifurcation stenting. Potential issues and solutions with crush techniques are described.
How to deal with CALCIFIED CORONARY ARTERY LESIONS .Coronary artery calcification (CAC) is highly prevalent in patients with coronary heart disease (CHD) and is associated with major adverse cardiovascular events. There are two recognized type of CAC—intimal and medial calcification, and each of them have specific risk factors. Several theories about the mechanism of vascular calcification have been put forward, and we currently believe that vascular calcification is an active, regulated process. CAC can usually be found in patients with severe CHD, and this asymptomatic phenomenon make early diagnosis of CAC important. Coronary computed tomographic angiography is the main noninvasive tool to detect calcified lesions. Measurement of coronary artery calcification by scoring is a reasonable metric for cardiovascular risk assessment in asymptomatic adults at intermediate risk. To date, effective medical treatment of CAC has not been identified. Several strategies of percutaneous coronary intervention have been applied to CHD patients with CAC, but with unsatisfactory results. Prognosis of CAC is still a major problem of CHD patients. Thus, more details about the mechanisms of CAC need to be elucidated in order to improve the understanding and treatment of CAC.
1) Bifurcation stenting approaches are based on the angiographic configuration of lesions in the main and side branches. Significant disease (>50% stenosis) in the side branch ostium increases the risk of side branch closure and restenosis.
2) The default approach is one-stent with provisional side branch treatment. Two-stent techniques are used if the side branch has significant disease and high closure risk features.
3) Techniques like crush, culotte, and T-stenting aim to provide full coverage of both branches, but have limitations and risks. Physiologic assessment with IVUS and FFR can help decide if jailed side branches require intervention.
1) Guidewire technology has advanced significantly with a wide selection for different lesion characteristics and vessel anatomies.
2) Guidewires consist of a core material, taper, tip style, coils, and various coatings which determine properties like flexibility and trackability.
3) The choice of guidewire depends on factors like vessel anatomy, lesion morphology, and the intended procedure or device. Workhorse wires are preferred for simple lesions while more complex cases require dedicated wires.
This is a comprehensive description of coronay lesion assessment from routinely used angiography to advanced imaging modalities like IVUS/OCT including their functional significance by FFR
No reflow and slow flow phenomenon during pcirahul arora
This document discusses strategies and prevention of slow flow and no-reflow phenomenon during percutaneous coronary intervention (PCI). It defines no-reflow as inadequate myocardial perfusion through a coronary artery without mechanical obstruction. No-reflow occurs in 8-11% of primary PCIs and is associated with worse clinical outcomes. The pathophysiology involves distal embolization, ischemic injury, reperfusion injury, and individual patient susceptibility. Preventing no-reflow requires reducing thrombus burden, ischemia time, reperfusion injury through anti-inflammatory drugs, and addressing risk factors like diabetes.
Coronary artery perforation during percutaneous coronary intervention (PCI) can be classified based on its anatomical location and severity. Proximal or midvessel perforations carry a greater risk of complications while distal perforations often have a benign course. Treatment depends on the perforation type and severity, with supportive measures, prolonged balloon inflation, covered stents, or vessel occlusion techniques used for more severe cases. Emergency surgery may be needed for large perforations not responding to other treatments, though surgical outcomes in emergency settings are often disappointing.
The document defines no-reflow as inadequate myocardial perfusion through a coronary circulation segment without mechanical vessel obstruction. No-reflow occurs in 30% of patients after reperfusion for myocardial infarction and is associated with worse outcomes. It results from microvascular obstruction from distal embolization, ischemic injury, and reperfusion injury. Diagnosis involves assessing TIMI flow, myocardial blush grade, and imaging techniques. Prevention focuses on reducing embolization using thrombectomy or filters while treatment involves vasodilators like adenosine, verapamil, and glycoprotein IIb/IIIa inhibitors.
rotablation is procedure used in complex pci with heavily calcified lesion for adequate expansion of stent.if used in indicated case and well aware of contraindication is necessary for achieving good results.
Coronary Ostial stenting techniques:Current statusPawan Ola
Ostial lesions, located within 3 mm of a vessel origin, pose unique challenges for percutaneous coronary intervention (PCI). Precise stent placement is required to avoid geographic miss and ensure optimal coverage of the lesion. Several techniques have been developed to aid accurate stent placement for ostial lesions, including aorto-free floating wire, stent pull-back, and Szabo/anchor wire methods. The use of these targeted approaches can reduce the risk of additional stenting and reintervention compared to conventional PCI for ostial lesions.
This document discusses complications that can occur during percutaneous coronary intervention (PCI), specifically contrast-induced nephropathy and coronary perforation. It defines contrast-induced nephropathy as acute kidney injury occurring after administration of radiocontrast media. Coronary perforation is defined as extravasation of contrast or blood from the coronary artery during or after PCI. The document discusses risk factors, prevention, diagnosis and management of these complications.
This document discusses evidence related to drug-coated balloons (DCBs) for the treatment of below-the-knee peripheral artery disease. It summarizes key studies including the DEBATE-BTK trial which found that DCBs reduced restenosis compared to angioplasty alone at 1 year. It also summarizes the IN.PACT DEEP trial, the first large randomized trial of DCBs for below-the-knee lesions, which did not meet its primary endpoints of reducing late lumen loss or reintervention rates compared to angioplasty alone at 1 year, though it did meet its primary safety endpoint of non-inferiority. Upcoming randomized controlled trials are
This document discusses optical coherence tomography (OCT) in coronary artery disease. It provides an overview of OCT, including its history and clinical evidence. It then outlines how to perform an OCT study and presents an algorithmic approach to interpreting OCT images, including assessing plaque morphology, stent sizing and apposition. The document discusses several clinical applications of OCT, such as evaluating acute coronary syndrome, plaque vulnerability, and stent failure. It also reviews limitations and future directions of OCT, including hybrid OCT/IVUS catheters and the use of artificial intelligence.
Stent thrombosis is a rare but devastating complication occurring in less than 1% of patients within 30 days of stenting and 0.2-6% annually afterwards. It is associated with higher thrombus burden and less procedural success, resulting in higher rates of death, recurrent heart attack, and recurrent stent thrombosis. Risk factors include stent-related issues like early versus late thrombosis, procedure-related issues like incomplete apposition or expansion, vessel-related issues like long lesions or small vessel size, and patient-related issues like diabetes, impaired heart function, renal disease, or non-compliance with dual anti-platelet therapy. Management depends on thrombus burden grade, with direct angioplasty and stenting for small burdens and
Coronary artery dissection and perforationFuad Farooq
Coronary artery dissection and perforation are serious potential complications of percutaneous coronary intervention (PCI) that can be life-threatening. Up to 30% of conventional balloon angioplasties result in angiographically significant coronary artery dissection. Perforation occurs in 0.3-0.6% of all PCI cases. The development of devices to remove or ablate tissue has increased the risk of these complications. Types C through F dissections according to the NHLBI classification portend significant morbidity and mortality if untreated, as they can lead to total coronary occlusion without blood flow. Acute vessel closure was the most feared complication before stents but now occurs in less than 1% of elective PCI due to stenting
This document discusses strategies and techniques for managing chronic total occlusions (CTO). It provides details on the histopathology of CTOs and explains why recanalizing them can provide clinical benefits like relieving angina and improving left ventricular function. It describes various CTO management techniques including pre-procedure planning, guide catheter selection, and use of specialized CTO guidewires. Predictors of procedural success and failure are also reviewed.
Chronic Total Occlusions: The Road Less TraveledAllina Health
By M. Nicholas Burke, MD. The use of pioneering percutaneous treatments for chronic total occlusions: indications, limitations, outcomes and current research.
This document discusses strategies and techniques for managing chronic total occlusions (CTO). CTOs are coronary blockages that are completely blocked for more than 3 months. The document outlines the histopathology of CTOs and factors that predict success or failure of percutaneous coronary intervention (PCI). It also describes various guidewires, microcatheters, and crossing devices that can be used to recanalize CTOs via antegrade or retrograde approaches. Successful PCI of CTOs has been shown to improve angina, reduce the need for bypass surgery, and improve survival.
This document discusses chronic total occlusion (CTO) of coronary arteries. It defines CTO and differentiates it from functional occlusions and pseudo-occlusions. The prevalence of CTO is estimated to be around 15% based on registry data. CTOs present technical challenges for percutaneous coronary intervention (PCI) due to factors like lesion length, calcification, and tortuosity. Proper preparation is important for CTO PCI, including adequate guide support and anticoagulation. Scoring systems can help predict the difficulty of crossing a CTO. Special guidewires and techniques may be needed depending on the lesion characteristics and collateral pathways.
The document summarizes various strategies for managing thrombus burden during primary angioplasty for myocardial infarction. It discusses thrombus grading scales, the composition and types of thrombus, and the role of medications like GP IIb/IIIa inhibitors (abciximab, tirofiban, eptifibatide), heparin, and bivalirudin. It also compares intracoronary versus intravenous administration of these drugs and evaluates trials comparing different treatment strategies. Mechanical thrombectomy devices and a combined pharmacologic and mechanical approach are also reviewed.
Stent thrombosis is a rare but serious complication of percutaneous coronary intervention (PCI) with mortality rates between 25-40%. It is classified based on timing (acute, subacute, late, very late) and etiology (primary, secondary). Risk factors include premature discontinuation of dual antiplatelet therapy, smoking, diabetes, chronic kidney disease, acute coronary syndrome, and high platelet reactivity. Strategies to minimize stent thrombosis involve careful patient selection, optimal stent deployment, adherence to potent dual antiplatelet regimens, and treatment involving emergent thrombectomy with escalated antiplatelet therapy.
The document discusses approaches to bifurcation lesions in coronary arteries. It defines a bifurcation lesion as a lesion located at the bifurcation of a main branch and side branch. Some key points discussed include:
- Provisional stenting of the main branch with adjunctive treatment of the side branch is generally the preferred initial approach.
- Double stenting techniques like culotte stenting and crush stenting are more complex but may be needed for large side branches or complex lesions.
- Factors like side branch size, angle of bifurcation, and extent of disease impact treatment decisions between single versus double stenting.
- Techniques for wiring the side branch, optimizing stent placement, and treating
The document discusses various stenting strategies for treating coronary bifurcation lesions, including newer advancements. It summarizes findings on stent thrombosis and major adverse cardiac event rates from randomized trials comparing one-stent versus two-stent approaches. It also outlines techniques for provisional stenting, elective double stenting, crush and sleeve methods, and left main coronary artery bifurcation stenting. Potential issues and solutions with crush techniques are described.
How to deal with CALCIFIED CORONARY ARTERY LESIONS .Coronary artery calcification (CAC) is highly prevalent in patients with coronary heart disease (CHD) and is associated with major adverse cardiovascular events. There are two recognized type of CAC—intimal and medial calcification, and each of them have specific risk factors. Several theories about the mechanism of vascular calcification have been put forward, and we currently believe that vascular calcification is an active, regulated process. CAC can usually be found in patients with severe CHD, and this asymptomatic phenomenon make early diagnosis of CAC important. Coronary computed tomographic angiography is the main noninvasive tool to detect calcified lesions. Measurement of coronary artery calcification by scoring is a reasonable metric for cardiovascular risk assessment in asymptomatic adults at intermediate risk. To date, effective medical treatment of CAC has not been identified. Several strategies of percutaneous coronary intervention have been applied to CHD patients with CAC, but with unsatisfactory results. Prognosis of CAC is still a major problem of CHD patients. Thus, more details about the mechanisms of CAC need to be elucidated in order to improve the understanding and treatment of CAC.
1) Bifurcation stenting approaches are based on the angiographic configuration of lesions in the main and side branches. Significant disease (>50% stenosis) in the side branch ostium increases the risk of side branch closure and restenosis.
2) The default approach is one-stent with provisional side branch treatment. Two-stent techniques are used if the side branch has significant disease and high closure risk features.
3) Techniques like crush, culotte, and T-stenting aim to provide full coverage of both branches, but have limitations and risks. Physiologic assessment with IVUS and FFR can help decide if jailed side branches require intervention.
1) Guidewire technology has advanced significantly with a wide selection for different lesion characteristics and vessel anatomies.
2) Guidewires consist of a core material, taper, tip style, coils, and various coatings which determine properties like flexibility and trackability.
3) The choice of guidewire depends on factors like vessel anatomy, lesion morphology, and the intended procedure or device. Workhorse wires are preferred for simple lesions while more complex cases require dedicated wires.
This is a comprehensive description of coronay lesion assessment from routinely used angiography to advanced imaging modalities like IVUS/OCT including their functional significance by FFR
No reflow and slow flow phenomenon during pcirahul arora
This document discusses strategies and prevention of slow flow and no-reflow phenomenon during percutaneous coronary intervention (PCI). It defines no-reflow as inadequate myocardial perfusion through a coronary artery without mechanical obstruction. No-reflow occurs in 8-11% of primary PCIs and is associated with worse clinical outcomes. The pathophysiology involves distal embolization, ischemic injury, reperfusion injury, and individual patient susceptibility. Preventing no-reflow requires reducing thrombus burden, ischemia time, reperfusion injury through anti-inflammatory drugs, and addressing risk factors like diabetes.
Coronary artery perforation during percutaneous coronary intervention (PCI) can be classified based on its anatomical location and severity. Proximal or midvessel perforations carry a greater risk of complications while distal perforations often have a benign course. Treatment depends on the perforation type and severity, with supportive measures, prolonged balloon inflation, covered stents, or vessel occlusion techniques used for more severe cases. Emergency surgery may be needed for large perforations not responding to other treatments, though surgical outcomes in emergency settings are often disappointing.
The document defines no-reflow as inadequate myocardial perfusion through a coronary circulation segment without mechanical vessel obstruction. No-reflow occurs in 30% of patients after reperfusion for myocardial infarction and is associated with worse outcomes. It results from microvascular obstruction from distal embolization, ischemic injury, and reperfusion injury. Diagnosis involves assessing TIMI flow, myocardial blush grade, and imaging techniques. Prevention focuses on reducing embolization using thrombectomy or filters while treatment involves vasodilators like adenosine, verapamil, and glycoprotein IIb/IIIa inhibitors.
rotablation is procedure used in complex pci with heavily calcified lesion for adequate expansion of stent.if used in indicated case and well aware of contraindication is necessary for achieving good results.
Coronary Ostial stenting techniques:Current statusPawan Ola
Ostial lesions, located within 3 mm of a vessel origin, pose unique challenges for percutaneous coronary intervention (PCI). Precise stent placement is required to avoid geographic miss and ensure optimal coverage of the lesion. Several techniques have been developed to aid accurate stent placement for ostial lesions, including aorto-free floating wire, stent pull-back, and Szabo/anchor wire methods. The use of these targeted approaches can reduce the risk of additional stenting and reintervention compared to conventional PCI for ostial lesions.
This document discusses complications that can occur during percutaneous coronary intervention (PCI), specifically contrast-induced nephropathy and coronary perforation. It defines contrast-induced nephropathy as acute kidney injury occurring after administration of radiocontrast media. Coronary perforation is defined as extravasation of contrast or blood from the coronary artery during or after PCI. The document discusses risk factors, prevention, diagnosis and management of these complications.
This document discusses evidence related to drug-coated balloons (DCBs) for the treatment of below-the-knee peripheral artery disease. It summarizes key studies including the DEBATE-BTK trial which found that DCBs reduced restenosis compared to angioplasty alone at 1 year. It also summarizes the IN.PACT DEEP trial, the first large randomized trial of DCBs for below-the-knee lesions, which did not meet its primary endpoints of reducing late lumen loss or reintervention rates compared to angioplasty alone at 1 year, though it did meet its primary safety endpoint of non-inferiority. Upcoming randomized controlled trials are
This document discusses optical coherence tomography (OCT) in coronary artery disease. It provides an overview of OCT, including its history and clinical evidence. It then outlines how to perform an OCT study and presents an algorithmic approach to interpreting OCT images, including assessing plaque morphology, stent sizing and apposition. The document discusses several clinical applications of OCT, such as evaluating acute coronary syndrome, plaque vulnerability, and stent failure. It also reviews limitations and future directions of OCT, including hybrid OCT/IVUS catheters and the use of artificial intelligence.
Stent thrombosis is a rare but devastating complication occurring in less than 1% of patients within 30 days of stenting and 0.2-6% annually afterwards. It is associated with higher thrombus burden and less procedural success, resulting in higher rates of death, recurrent heart attack, and recurrent stent thrombosis. Risk factors include stent-related issues like early versus late thrombosis, procedure-related issues like incomplete apposition or expansion, vessel-related issues like long lesions or small vessel size, and patient-related issues like diabetes, impaired heart function, renal disease, or non-compliance with dual anti-platelet therapy. Management depends on thrombus burden grade, with direct angioplasty and stenting for small burdens and
Coronary artery dissection and perforationFuad Farooq
Coronary artery dissection and perforation are serious potential complications of percutaneous coronary intervention (PCI) that can be life-threatening. Up to 30% of conventional balloon angioplasties result in angiographically significant coronary artery dissection. Perforation occurs in 0.3-0.6% of all PCI cases. The development of devices to remove or ablate tissue has increased the risk of these complications. Types C through F dissections according to the NHLBI classification portend significant morbidity and mortality if untreated, as they can lead to total coronary occlusion without blood flow. Acute vessel closure was the most feared complication before stents but now occurs in less than 1% of elective PCI due to stenting
This document discusses strategies and techniques for managing chronic total occlusions (CTO). It provides details on the histopathology of CTOs and explains why recanalizing them can provide clinical benefits like relieving angina and improving left ventricular function. It describes various CTO management techniques including pre-procedure planning, guide catheter selection, and use of specialized CTO guidewires. Predictors of procedural success and failure are also reviewed.
Chronic Total Occlusions: The Road Less TraveledAllina Health
By M. Nicholas Burke, MD. The use of pioneering percutaneous treatments for chronic total occlusions: indications, limitations, outcomes and current research.
A 56-year-old male with a history of heart disease presented with ongoing chest pain after an unsuccessful attempt to open a chronic total occlusion of the right coronary artery via percutaneous coronary intervention 6 weeks prior. The patient underwent a second PCI procedure where the CTO was successfully opened using an antegrade approach, resolving his symptoms. At follow-ups 6 months, 12 months and 18 months later, the patient reported continued relief from symptoms and was able to return to exercising and training for triathlons without any chest pain.
Migration of thrombus in coronary arteriesYevgeniy Moon
This document summarizes a case report of a thrombus migrating during a percutaneous coronary intervention (PCI) for a heart attack. A 69-year-old woman presented with chest pain and was found to have a blocked left anterior descending coronary artery. During balloon angioplasty of this artery, the thrombus migrated downstream, blocking a side branch artery. Further interventions restored blood flow in this new blocked artery. The summary cautions that thrombus migration is a risk during PCI and operators should pay attention to side branches as well as the initial blocked artery. Aspiration catheters may help reduce this complication risk.
This document discusses coronary guidewires used in percutaneous coronary intervention (PCI). It describes the components, classifications, and appropriate uses of guidewires for different clinical scenarios. Guidewires are classified based on tip flexibility, device support, coating, and tip load. Commonly used guidewires include Balance Middleweight Universal, Choice Floppy, and BMW. Guidewire selection depends on vessel anatomy, lesion morphology, devices used, and operator experience. Special guidewires are discussed for procedures like left main PCI, bifurcation PCI, dissections, calcified lesions, and chronic total occlusions.
Coronary collaterals are natural bypass connections between portions of the same coronary artery and between different coronary arteries. They form in response to rapid occlusion of arterial vessels from coronary artery disease or exercise. Collaterals help supply blood to ischemic heart regions caused by artery blockages, providing an alternate blood flow route when the heart isn't getting enough blood. This collateral circulation protects the heart muscle from infarction during ischemia and improves survival rates in patients experiencing a heart attack.
This document discusses techniques for using double lumen catheters in CTO-PCI procedures. It describes the limitations of classic reverse CART techniques and recommends using GAIA wires for retrograde wiring with careful antegrade preparation. For short CTOs, direct retrograde wiring can work well with GAIA with or without IVUS. But for long CTOs with unknown vessel trajectory, careful antegrade preparation is needed to avoid perforation, and alternative non-tapered wires may be preferable to GAIA for staying inside the vessel. The document provides tips for reverse CART including doing antegrade ballooning close to the CTO end, being careful of antegrade wire position, and not using retrograde GAIA if
This document discusses strategies for chronic total occlusion percutaneous coronary intervention (CTO PCI), specifically the criteria for choosing an antegrade versus retrograde approach. The key points are:
1) An antegrade wire should generally be placed first before attempting a retrograde approach to help connect the wires and reduce retrograde dwelling time.
2) Exceptions include when targeting ostial lesions or bifurcations where antegrade wiring risks side branch loss.
3) The decision of when to stop antegrade wiring and switch to retrograde depends on the specific lesion characteristics and may require balancing wire passage risks with procedural time.
Alfredo R. Galassi - How to deal with very LVEF: the last remaining option to...Euro CTO Club
This document summarizes a presentation on CTO PCI in patients with multiple vessel disease and low left ventricular ejection fraction (LVEF). The presentation discusses:
1. The importance of assessing viability and ischemia before revascularization.
2. The need for hemodynamic support, particularly when using retrograde approaches.
3. Tips for procedural success including using the easiest CTO first and considering staged procedures.
4. The debate around complete vs. incomplete revascularization and factors to consider.
5. The importance of clinical and angiographic follow-up given the risk of restenosis in this complex patient group.
08:05 Escaned - Final cto training for allEuro CTO Club
This document discusses the need for more operators to be trained in treating chronic total occlusions (CTOs) with percutaneous coronary intervention (PCI). It notes that while success rates for standard PCI procedures are now over 95% for most operators, success rates for CTO PCI have remained around 50% for untrained operators but are 80-90% for trained operators. It argues that low CTO PCI success rates have led to undertreatment of patients with clinical indications for CTO revascularization. Expert clubs have helped standardize CTO PCI approaches and increased success rates to around 80-90%, but adoption of these approaches among general interventionalists remains low due to obstacles like established habits and perceptions of CTO PCI as requiring specialized skills
This study assessed the outcomes of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in elderly patients aged 75 years and older compared to younger patients. The study found that CTO PCI success rates were similar between those aged 75+ and younger. While major adverse cardiac event rates were higher in the elderly, successful revascularization was associated with reduced MACE and cardiac mortality at 5-year follow-up in both age groups. The conclusion is that age alone should not determine PCI eligibility and that CTO PCI can provide benefits in elderly patients similar to younger patients when clinically appropriate.
11:20 Louvard - adjusting your level of competence to the difficulty of a CTOEuro CTO Club
1) Adjusting the difficulty level of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) cases to the skill level of the operator is important. This can be done through patient selection based on predictors of success and operator experience.
2) A team-based approach, use of new devices and techniques, individual case volumes, and proctoring can help improve CTO PCI success rates.
3) Scores like the J-CTO score and the new CL-SCORE can help predict procedural success and guide patient selection and referral. Maintaining a database is useful for monitoring outcomes and individual operator success.
Georgios Sianos - RETROGRADE STEP BY STEP APPROACHEuro CTO Club
This document provides an overview of retrograde techniques for recanalizing chronic total occlusions (CTOs). It discusses the history and evolution of retrograde techniques, including septal collateral crossing and dilatation. Key steps in the retrograde approach like wire escalation, dissection and re-entry are outlined. Case examples demonstrate the retrograde procedure in detail. Consensus recommendations emphasize the importance of operator experience before performing retrograde CTO PCI independently. Required lab set-up and equipment are also reviewed.
11:35 CASE 3 Lefevre - impossible to crossEuro CTO Club
A 70-year-old male presented with pulmonary edema and was found to have an anterior myocardial infarction with total occlusion of the mid-LAD and intermediate lesion in the distal RCA. Angiography showed collaterals from the RCA to the LAD via a septal channel. Attempts to cross the CTO in the LAD with a balloon and wire were unsuccessful. The next steps considered were either using antegrade laser ablation or a retrograde approach through the septal collaterals. Ultimately, antegrade laser ablation was successful after 3 hours and 42 minutes, improving the patient's ejection fraction from 30% to 47% at 6-month follow up.
15:35 Rinfret - Wire maneuvers in retrogade PCIEuro CTO Club
1) Retrograde PCI requires specific wire maneuvers to be mastered, including septal channel surfing, straight wire fast drilling, controlled drilling with sharp wires, and using knuckled wires.
2) These techniques allow for retrograde crossing of collateral channels, occluded grafts, and CTO lesions.
3) With practice of these simple maneuvers, retrograde PCI can be performed safely and effectively.
The document discusses strategies for percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs). It describes:
1. The antegrade approach is the most commonly used, with success rates of 60-80%. Tapered guidewires are first-choice to probe microchannels.
2. A four-wire strategy is recommended, starting with a polymer-coated wire and progressing to stiffer wires if needed.
3. Advanced techniques like parallel wiring or antegrade dissection and reentry may be used if initial wiring fails.
Despite the advances in wire technology and development of algorithm-driven methodology for chronic
total occlusion (CTO) intervention, there is a void in the literature about the technical aspects of CTO wiring.
The Asia Pacific CTO Club, a group of 10 experienced operators in the Asia Pacific region, has tried to fill this
void with this state-of-the-art review on CTO wiring
This document discusses techniques for crossing chronic total occlusions (CTOs) during percutaneous coronary intervention. It describes the distal cap penetration technique using a reverse controlled antegrade and retrograde subintimal tracking (CART) approach. Key aspects of CTO wiring are discussed, including wire features needed for penetration, pushability, steerability, and shaping memory. Retrograde strategies and hardware options are presented, including parallel wiring, the star technique, and snaring. The document shares experience from over 300 CTO cases with a high success rate and low complications.
Daniel Weilenmann - Guidewiresand microcatheters: how to useEuro CTO Club
The document discusses guidewires and microcatheters for chronic total occlusion procedures. It provides classifications of guidewires including conventional, support, and CTO wires. It describes specific guidewires such as Pilot 200 and Fielder XT and their uses for tasks like penetration, tortuosity, and knuckling. Microcatheters discussed include Corsair, Caravel, and Turnpike. The document presents a hybrid algorithm for CTO crossing incorporating both antegrade and retrograde approaches depending on lesion characteristics.
This document discusses techniques for chronic total occlusion (CTO) recanalization. It describes analysis of data from the UK Central Cardiac Audit Database on over 13,000 patients who underwent elective CTO percutaneous coronary intervention (PCI) between 2005-2009. The document reports that successful revascularization is associated with reduced mortality. It also provides an overview of the CTO PCI timeline and techniques that have been developed for CTO recanalization, including wires, microcatheters, intravascular ultrasound (IVUS), and balloons.
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are often calcified and have limited re-entry options compared to superficial femoral artery occlusions. New guidewires, support catheters, re-entry devices, and CTO crossing devices can be used to cross tibial CTOs, and treatments may include angioplasty, cryoplasty, laser atherectomy, drug-eluting balloons, and stents. While plain old balloon angioplasty has shown poor long-term patency, combining techniques can achieve acute success and potentially allow wound healing.
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are often calcified and have limited re-entry options compared to superficial femoral artery occlusions. New guidewires, support catheters, coronary CTO wires, re-entry devices, and tibial CTO-specific devices can help cross these lesions. Acute procedural success may involve angioplasty, cryoplasty, laser/atherectomy, drug-eluting balloons, or stents. However, long-term patency with angioplasty alone is poor. Retrograde and alternative access techniques can also help treat tibial CTOs previously seen as unapproach
This document discusses techniques for treating complex tibial chronic total occlusions (CTOs). It notes that tibial CTOs are more challenging than superficial femoral artery occlusions due to calcification, limited re-entry options, and difficulty visualizing distal vessels. New guidewires, support catheters, re-entry devices, and CTO crossing devices can help cross tibial CTOs. Acute procedural success can be achieved with angioplasty, cryoplasty, atherectomy, drug-coated balloons, or drug-eluting stents, but long-term patency with angioplasty alone is poor. Novel techniques and devices have increased the number of previously untreatable tibial C
This document provides tips and tricks for treating chronic total occlusions (CTOs). It discusses:
1. The challenges of CTOs including bending, calcification, long lesions, and complex entry/exit points.
2. The need to select devices appropriately for each case, including guidewires tailored for different lesion characteristics and IVUS guidance.
3. Techniques for using different guidewire types to penetrate microchannels, modify calcified/bending lesions, and penetrate hard lesions.
4. The importance of selecting the right retrograde channel and devices, with the goal of making an antegrade-retrograde connection, as in traditional retrograde techniques.
5. Encourage
Basic of PCI through Trans Radial RouteAshok Dutta
1. The document discusses the basics of percutaneous coronary intervention (PCI) through the transradial approach. It covers the history, access routes, procedural steps, guide catheter selection, complications and tips for successful PCI.
2. Key points include that the radial approach has a narrow pathway but fewer complications compared to the femoral approach. Guide catheter size selection depends on the vessel diameter and intended devices. Wiring, balloon angioplasty, stenting and post-dilatation are the standard steps of PCI.
3. Complications include dissection, perforation and stent malapposition. Tips provided to prevent complications and ensure procedural success include proper guide catheter and device selection, gentle manipulation, and frequent
Optimize guide catheter support
Fabrice Leroy, Lille, France
11th Experts Live CTO
The annual Euro CTO meeting
September 13th –14th, 2019 - Berlin, Germany
This document discusses techniques for retrograde CTO procedures including reverse CART. It describes the wires and microcatheters used for septal and epicardial collateral crossings. The Suoh 0.3 guidewire is highlighted for its soft tip and flexibility. Different types of reverse CART techniques are defined including conventional, directed, and extended. Contemporary directed reverse CART is noted as superior with less vessel trauma. Recent data shows success rates of 80% using reverse CART and its usage in 55% of retrograde cases. The document concludes with key learnings around mastering antegrade techniques first before retrograde and emphasizing hardware knowledge and proctorship.
Session 3 - Retrograde approach – EUROCTO algorithmEuro CTO Club
This document provides an overview of retrograde approaches for treating chronic total occlusions (CTOs). It discusses the Euro CTO algorithm and notes that retrograde procedures are primarily used in more complex cases as determined by the J-CTO score. The success rates of retrograde procedures are around 80% overall but have increased as operators have gained more experience and new microcatheters and guidewires have been developed. Reverse controlled antegrade and retrograde subintimal tracking (Reverse CART) is the preferred retrograde technique, but different variations of Reverse CART exist depending on the characteristics of the CTO.
The document discusses the history and development of coronary stents. It begins by describing how stents originated from a dental prosthesis and have evolved from early balloon angioplasty techniques. It then covers the key limitations of bare-metal stents that led to the development of drug-eluting stents. The document provides detailed information on stent design features including composition, configuration, coatings, and the benefits of different designs. It also discusses the ideal properties for coronary stents and compares balloon-expandable and self-expanding stents.
The document discusses techniques for recanalizing chronic total occlusions (CTOs) in coronary arteries. It provides an overview of success rates for CTO recanalization, which range from 65-79%. It also describes various antegrade and retrograde wire techniques used to recanalize CTOs including parallel wire techniques, side branch techniques, subintimal re-entry techniques, and the controlled antegrade and retrograde subintimal tracking (CART) technique. More recently, devices like the Crosser system and Spectranetics have been developed to aid in CTO recanalization.
Collateral crossing requires careful evaluation of angiograms to select the optimal collateral connection. Parameters like size, tortuosity, and insertion angle must be considered. Septal channels are initially approached with septal surfing to gently slide the wire through. If this fails, targeted crossing with tip injections may help reveal channel anatomy. Proper guidewire support and balloon anchoring can aid microcatheter advancement when issues arise. The goal is to safely cross collaterals and restore blood flow to the occluded vessel.
2017 ESC guidelines for the management of acuteIqbal Dar
The document summarizes key messages from the 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. It discusses 14 main points, including the epidemiology of STEMI, the importance of equal treatment for women and men, ECG diagnosis criteria, reperfusion strategy selection, the role of cardiac networks and protocols, antithrombotic therapy, imaging, special patient subsets, and quality indicators for auditing and improving STEMI care. The guidelines emphasize timely reperfusion therapy, coordination across emergency services and hospitals, and evidence-based treatments tailored to individual patient characteristics and circumstances.
This document discusses the management of hypertrophic cardiomyopathy (HCM). It covers the natural history of HCM, risk stratification including the role of implantable cardioverter defibrillators, pharmacological treatments, and invasive treatments such as alcohol septal ablation and surgical myectomy. Key points discussed include the use of beta blockers as first-line pharmacological therapy, guidelines for ICD implantation, the technique and outcomes of alcohol septal ablation versus surgical myectomy, and recommendations for experienced centers to perform these invasive procedures.
ARVC is a heritable heart muscle disorder that predominantly affects the right ventricle. It is caused by genetic defects in cardiac desmosomes, which are important for cell-to-cell adhesion. This leads to progressive loss of right ventricular myocardium and replacement by fibrofatty tissue. ARVC can cause dangerous ventricular arrhythmias and is a leading cause of sudden cardiac death in young people. Diagnosis involves imaging tests and electrocardiography to detect right ventricular structural abnormalities and arrhythmias.
Guideline for the management of heart failureIqbal Dar
This document provides guidelines for the management of heart failure. It defines heart failure and outlines the stages from A to D. It recommends obtaining a thorough history and physical exam, diagnostic tests including biomarkers, and noninvasive cardiac imaging for initial and serial evaluation of heart failure patients. Invasive hemodynamic monitoring is recommended for selected patients with acute heart failure and impaired perfusion. Invasive coronary angiography is reasonable when ischemia may be contributing to heart failure.
This document discusses neurocardiogenic syncope, specifically vasovagal syncope (VVS). It covers the pathophysiology, diagnosis, and treatment of VVS. Regarding diagnosis, it discusses head-up tilt table testing (HUTT) and implantable loop recorders (ILRs). While HUTT can help diagnose susceptibility to neurally-mediated syncope, its sensitivity, specificity, and prognostic value are limited. ILRs provide reproducible diagnostic information during spontaneous spells. Treatment focuses on non-pharmacological measures like education, salt/water intake, orthostatic training, and counterpressure maneuvers.
Pacemakers have several key components including a battery, circuitry, connector block, and leads. Battery technology has evolved from mercury zinc to lithium iodium batteries with longer lifespans. Pacemaker circuitry is now highly integrated with microprocessors and data storage. Leads contain electrodes, insulation, and fixation mechanisms. Pacemakers can be programmed to function in different modes depending on sensing and pacing of the atria and ventricles. Parameters like rate response, refractory periods, and mode switching algorithms allow pacemakers to function adaptively based on patient activity and heart rhythm.
This document discusses transvenous lead extraction. It begins by providing background on the history of pacemakers and leads. It then defines various terms related to lead removal, extraction, and the different tools and techniques used. It discusses recommendations for operator training and facility requirements. Finally, it outlines the Heart Rhythm Society guidelines for indications for lead removal, including infection, pain, thrombosis, functional and non-functional leads. The guidelines classify recommendations as Class I, IIa, IIb or III based on evidence levels.
The HOPE-3 trial found that combining treatment with rosuvastatin, candesartan, and hydrochlorothiazide reduced the risk of cardiovascular events by 29% compared to placebo in a population at intermediate cardiovascular risk. The combination therapy lowered LDL cholesterol by 33.7 mg/dL and systolic blood pressure by 6.2 mmHg on average over 5.6 years. It reduced the risk of the primary composite outcome of cardiovascular death, myocardial infarction, or stroke compared to placebo, with numbers needed to treat of 72 and 63 to prevent an event in the primary outcomes. Subgroup analyses suggested greater benefit for those with higher baseline blood pressure.
Complete revascularization in patients with multivessel disease undergoing primary PCI was associated with a small increase in additional infarction in non-IRA territories compared to IRA-only revascularization. However, total infarct size and measures of cardiac function were similar between the two groups both before discharge and at 9 month follow up. While complete revascularization led to more type 4a MIs, the increased risk did not negatively impact clinical outcomes.
- The LEADERS FREE trial compared outcomes of patients at high risk of bleeding who received either a polymer-free drug-coated stent releasing umirolimus (BioFreedom stent) or a bare-metal stent, both with 1 month of dual antiplatelet therapy.
- Use of the drug-coated stent was associated with lower rates of the primary safety composite of cardiac death, MI, or stent thrombosis and the primary efficacy endpoint of clinically-driven TLR compared to the bare-metal stent.
- The drug-coated stent showed benefit over the bare-metal stent in reducing rates of MI, likely driven by lower rates of in-stent restenosis, without increasing the risk of bleeding which
This document summarizes the MATRIX study which compared the effectiveness of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive treatment. The study included two randomized trials involving over 7,000 patients total comparing the drugs. At 30 day follow up, major adverse cardiovascular events occurred in 10.3% of the bivalirudin group versus 10.9% of the heparin group, showing bivalirudin was not superior to heparin for reducing ischemic outcomes while potentially reducing bleeding risks.
The SPRINT trial studied over 9,000 patients at high risk for cardiovascular events to compare intensive blood pressure control (target <120 mm Hg systolic) to standard control (target <140 mm Hg). It found that intensive control significantly reduced rates of fatal and nonfatal heart attacks, heart failure, and death from any cause. However, intensive control also increased some adverse effects like acute kidney injury and hypotension. Overall, the trial demonstrated benefits of very tight blood pressure control for high-risk patients without diabetes.
Portal of entry of infective endocarditisIqbal Dar
This study systematically searched for present and potential portals of entry for infective endocarditis (IE) among 444 patients hospitalized for definite IE. The present portals of entry were identified in 74% of patients, with the most common being cutaneous (40%), oral/dental (29%), and gastrointestinal (23%). Potential future portals of entry were also investigated, such as ongoing intravenous drug use (21% of patients), oral/dental infections (53%), and colonic lesions (40%). The study demonstrated the feasibility and value of systematically searching for IE portals of entry.
Bangkok Declaration oral health at the global radar.pdfWeam Banjar
An effort to enhance oral health research and shed light ongoing global efforts to integrate oral health into healthcare systems and national health programs.
Midfacial degloving is a useful approach for sinonasal and skull base lesions. This technique provides wide exposure for a variety of pathologies without needing facial incisions.
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptxzeelm1995
Silent Signals: Recognizing Early Markers in Hematologic Malignancies is a clinical presentation designed to raise awareness among healthcare professionals about the often-overlooked early indicators of blood cancers such as chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and multiple myeloma (MM). These malignancies can begin with subtle, nonspecific symptoms—often mistaken for benign conditions—leading to delayed diagnoses and suboptimal patient outcomes.
This presentation walks the audience through the critical importance of early detection in hematologic malignancies. It begins by establishing the clinical and emotional impact of delayed diagnoses, highlighting that up to 30% of blood cancers may initially present with vague symptoms like fatigue, recurrent infections, or mild lab abnormalities. These “silent signals” are frequently dismissed or misattributed, emphasizing the need for clinicians to maintain a high index of suspicion.
Through a structured four-part approach, the slides explore:
The Stakes of Early Detection
Understand why timing matters. This section provides key statistics on survival rates and emotional burden, and it contrasts benign explanations with red-flag symptoms, enabling clinicians to differentiate between common ailments and potential warning signs of malignancy.
Lab Markers That Matter
Subtle shifts in routine blood work can be crucial. Clinicians are guided to recognize how markers like elevated LDH, low hemoglobin, or abnormal WBC differentials may indicate deeper hematologic pathology. A simplified diagnostic pathway is provided to help connect clinical presentation to appropriate testing and specialist referral.
A Hidden Myeloma: Case Spotlight
A real-world case of a 55-year-old male patient illustrates how early symptoms—persistent fatigue, bone pain, and recurrent infections—were initially attributed to benign causes. The turning point came from diligent testing and interpretation of lab results (including SPEP and bone marrow biopsy), which led to a diagnosis 8 months earlier than the average. The outcome? A measurable clinical improvement, including very good partial response (VGPR) after prompt treatment initiation.
Key Learnings for Practice
This section summarizes actionable takeaways: think beyond the usual when symptoms linger, repeat and investigate unexplained lab anomalies, and ensure coordinated care between GPs, hematologists, and lab services. Clinician collaboration is not just helpful—it’s vital in reducing time to diagnosis and improving patient outcomes.
Whether you're a general practitioner, internist, or early-career specialist, this presentation equips you with the insights needed to better recognize the earliest signs of hematologic malignancies. The ultimate goal? Reduce diagnostic delay, initiate timely intervention, and improve survival and quality of life for patients with blood cancers.
Author: Zeel Mehta
Bone mineral density measurements in nuclear medicineMiadAlsulami
In every Nuclear Medicine department, DEXA scans are important and performed daily. It's crucial for us to accurately understand and interpret these scans.
This presentation is based on the series and flowcharts decisions to be made and of methods when dealing with a case of tooth avulsion in children (more specifically) and adults.
All references have been enumerated in the last slides.
Hit LIKE if you found this content helpful.
Chronic Obstructive Pulmonary Disease, NursingAnurag Joseph
Slide 1: Title Slide
Title: Understanding COPD: Definition, Diagnosis, Pathophysiology, Management, and Nursing Care Plan
Subtitle: A comprehensive guide for nursing students
Slide 2: Definition of COPD
Definition:
COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
Main characteristics:
Progressive airflow limitation
Often associated with smoking
Includes emphysema and chronic bronchitis
Slide 3: Types of COPD
Chronic Bronchitis:
Inflammation of bronchial tubes, leading to excess mucus production
Symptoms: Chronic cough, sputum production
Emphysema:
Damage to alveolar walls, leading to air trapping
Symptoms: Shortness of breath, barrel chest
Slide 4: Diagnosis of COPD
Methods of Diagnosis:
Pulmonary Function Test (PFT):
Measures forced expiratory volume (FEV1) and forced vital capacity (FVC)
Arterial Blood Gas (ABG):
Measures oxygen and CO2 levels
Chest X-ray/CT Scan:
Identifies lung damage
History and Symptoms:
Cough, sputum, and breathlessness history
Smoking history
Slide 5: Pathophysiology of COPD
Airflow Obstruction:
Chronic inflammation leading to narrowing of airways
Destruction of alveolar walls (emphysema)
Increased mucus production (chronic bronchitis)
Increased Work of Breathing:
Air trapping and limited gas exchange
Progressive Hypoxia & Hypercapnia:
Reduced oxygen supply and increased carbon dioxide retention
Slide 6: Management of COPD
Pharmacological Treatment:
Bronchodilators (Beta-agonists, Anticholinergics)
Corticosteroids (oral or inhaled)
Oxygen Therapy
Antibiotics (for infections)
Non-pharmacological Treatment:
Pulmonary Rehabilitation
Breathing exercises (e.g., pursed-lip breathing)
Lifestyle changes (e.g., smoking cessation)
Vaccinations (e.g., flu, pneumonia)
Slide 7: Nursing Care Plan for COPD
Assessment:
Monitor respiratory rate, lung sounds, oxygen saturation
Assess for signs of distress (e.g., use of accessory muscles)
Record smoking and environmental exposure history
Nursing Diagnoses:
Impaired Gas Exchange
Ineffective Airway Clearance
Activity Intolerance
Goals:
Maintain optimal oxygen levels
Enhance airway clearance
Increase physical activity tolerance
Interventions:
Administer bronchodilators and corticosteroids
Educate on smoking cessation
Promote breathing exercises and positioning
Ensure proper nutrition and hydration
Educate on recognizing exacerbations
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...PRAVEEN RAJA S
Isoquinoline alkaloid Berberine A Nutraceutical molecule for reducing HbA1c levels in Diabetes mellitus and Reversible of Fatty liver disease
#Maramanjal (berberis Aristata)
#Berberis Vulgaris
Grazi - Personalizing surgical strategy in HPB surgery.pptxGian Luca Grazi
The growing need to introduce guidelines for the optimal management of various pathological conditions has highlighted that only a certain percentage of patients can be correctly classified in these guidelines. Liver, pancreas and biliary tract diseases that require surgical treatment present this problem. The anatomical variables of individual patients and diseases that develop in unpredictable ways make it necessary to personalize treatment.
This scientific presentation analyzes the modern tools available to the medical community for the surgical treatment of hepato-biliary-pancreatic tumors. The potential of using "big data" is illustrated, in particular with the help of artificial intelligence, the application of 3D reconstruction models and virtual reality, and the use of vital dyes during minimally invasive surgical interventions.
Finally, it is emphasized that in daily clinical practice not all patients are treated following international guidelines. There are situations, such as the treatment of hepatocellular carcinoma, in which a significant portion of patients are treated with alternative approaches, even though these may yield inferior results compared to more aggressive but effective treatments.
This lecture was presented at the 142nd Congress of the German Society of Surgery (DCK 2025), held at the Congress Center Munich from 18 to 20 March 2025, in the session HPB International, with the original title "Personalizing surgical strategy in HPB surgery".
GIST , pathophysiology , diagnosis and management dr. amrish .pptxDr. Amrish Yadav
1) Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the Gl tract that arise from interstitial cells of Cajal.
2) GISTs most commonly occur in the stomach and small intestine and present with Gl bleeding, abdominal pain, or mass.
3) Diagnostic workup includes CT, endoscopy, and biopsy to establish a diagnosis, assess resectability, and identify mutations for targeted therapy.
4) Complete surgical resection is the main treatment, while adjuvant imatinib therapy helps maintain remission and unresectable tumors may be downstaged with neoadjuvant imatinib
Spondyloepiphyseal dysplasia is a mimicker of arthritisRitasman Baisya
Musculoskeletal involvement in children is often challenging, with a wide range of benign conditions, such as growing pain, to severe systemic diseases. Spondylo-epiphyseal dysplasia (SED) is an autosomal recessive disease of the skeletal system that often mimics juvenile idiopathic arthritis (JIA) with no response to anti-rheumatic therapy.
Case - A young male, 22 years of age, presented with a history of pain in his upper and lower back and multiple small and large joints since five years of age. He denied any morning stiffness or increased nocturnal pain. Previously, he was treated outside as juvenile idiopathic arthritis with methotrexate, sulfasalazine and injection Adalimumab. However, his mother denied any symptomatic improvement of his pain. On examination, his growth was stunted with significant kyphoscoliosis. (Figure 1 ) He had an antalgic gait with exaggerated lumbar lordosis. He had mild tenderness in both hips, knees and ankles with flexion contracture and bony swelling at bilateral proximal & distal interphalangeal joints (PIP and DIP), referred to as camptodactyly. (Figure 2 ) His cervical and lumbar movement was severely restricted, with bilateral hip movement restricted. Laboratory investigation showed normal ESR CRP. Rheumatoid factor was low titre positive, anti-CCP antibody and HLA-B27 by PCR were negative. His skeletal radiographic images showed platyspondyly in the thoracolumbar spine, epiphyseal widening in MCP and IP joints with ovoid carpal bones (Figure 3), platyspondyly in the thoracolumbar spine (Figure 4) , hip joint sclerosis . (Figure 5 ) His diagnosis was reconsidered as spondyloepiphyseal dysplasia (SED) . He was started with extensive physiotherapy and symptomatic pain relief treatment and noticed improvement in his pain and quality of life.
Brief discussion - SED predominantly involves articular cartilage, which results in joint stiffness and epiphyseal enlargement. Typically starting at 2-8 years of age, they manifest with pain, stiffness and swelling of extremity joints. (1) On examination, the swelling is predominantly bony without any evidence of inflammation. Over time, the large joints and the spine get involved, causing significant joint contractures, gait abnormality, kyphoscoliosis, abnormal posture and poor quality of life. There are reported cases where SED have been misdiagnosed as JIA with no response to immunomodulatory treatment. (1,2) SED's radiological features differ from JIA, with platyspondyly being an early finding in the skeletal image, epiphyseal enlargement, and lack of destructive joint erosions. Though SED is considered a rare entity, one large study by Dalal et al. (3) reported 35 cases of SED from 25 unrelated families with 11 different homozygous mutations and one instance of compound heterozygosity in the WISP3 gene. It proves that this entity is not very uncommon in India.
At Dr. Akshay's DentAvenue Dental Clinic in Chembur, expert dentists Dr. Akshay Bandewar and Dr. Saudnya Bandewar are committed to delivering comprehensive dental care with a focus on advanced treatments. Dr. Akshay, a leading prosthodontist, implantologist, and dental implants periodontist with 13 years of experience, specializes in full mouth rehabilitation, crown & bridge work, and smile designing, while Dr. Saudnya, an experienced endodontist, pediatric dentist, and laser dentist with 8 years of expertise, offers specialized treatments such as root canal therapy, pediatric dental care, and laser gum treatments. From orthodontics (traditional braces & Invisalign) to cosmetic dentistry, periodontics, teeth whitening services, and more, a wide array of treatments is available. Whether it's dental implants, a smile makeover, or routine dental care, Dr. Akshay and Dr. Saudnya ensure expert solutions tailored to every patient's needs. Visit today for advanced, compassionate, and personalized dental care.
Dr. Akshay Bandewar, the Founder of Dr. Akshay's DentAvenue Dental Clinic in Chembur, is an experienced Prosthodontist and Implantologist with over 13 years of expertise. He specializes in Dental implants in Chembur, Full Mouth Rehabilitation, Smile Designing, and a variety of restorative treatments. Dr. Akshay holds an MDS in Prosthodontics (Crown, Bridge, and Implantology) from Government Dental College, Mumbai, and has honed his skills in Crown, Bridge, and Implantology over the years. His comprehensive approach ensures that every patient receives personalized care, whether it's dental implants or smile makeover treatments. As a former assistant professor at Government Dental College, Mumbai, Dr. Akshay stays at the forefront of dental advancements. His clinic is equipped with state-of-the-art technology, providing precision and efficiency in all treatments. Whether you need Dental implants in Chembur or a complete smile restoration, Dr. Akshay offers expert solutions tailored to your needs. Trust his 13+ years of experience for the best dental care. Visit Dr. Akshay at Dr. Akshay’s DentAvenue for exceptional and personalized dental treatment.
Dr. Saudnya, Co-founder of Dr. Akshay's DentAvenue Dental Clinic in Chembur, with over 8 years of experience in the dental field. As an expert in Root Canals, Crowns, Bridges, Cosmetic Dentistry, Dentures, and more, she offers exceptional care to all her patients. Dr. Saudnya is also skilled in Pediatric Dental Treatment, ensuring a gentle approach for children’s dental needs.
Tags:- dental clinic in Chembur, dentist in Chembur, implantologist in Chembur, prosthodontist in Chembur, endodontist in Chembur, cosmetic dentist in Chembur, orthodontist in Chembur, periodontist in Chembur, pediatric dentist in Chembur, best dentist in Chembur.
Larsen's Human Embryology.pdfembryology for medical studentsKalluKullu
embryology for medical students,E verystudentwillbeaffectedbypregnancy,eithertheirmother’s,
because what happens in the womb does not necessarily stay in
the womb, or by someone else’s. As health care professionals, you will often
encounter women of childbearing age who may be pregnant, or you may
have children of your own, or maybe it is a friend who is pregnant. In any
case, pregnancy and childbirth are relevant to all of us, and unfortunately,
these processes often culminate in negative outcomes. For example, 50% of
all embryos are spontaneously aborted. Furthermore, prematurity and birth
defects are the leading causes of infant mortality and major contributors to
disabilities. Fortunately, new strategies can improve pregnancy outcomes,
and health care professionals have a major role to play in implementing
these initiatives. However, a basic knowledge of embryology is essential to
the success of these strategies, and with this knowledge, every health care
professional can play a role in providing healthier babies.Clinical Correlates: In addition to describing normal events, each
chapter contains clinical correlates that appear in highlighted boxes. This
material is designed to demonstrate the clinical relevance of embryology
and the importance of understanding key developmental events as a first
step to improving birth outcomes and having healthier babies. Clinical
pictures and case descriptions are used to provide this information, and
this material has been increased and updated in this edition.
Genetics: Because of the increasingly important role of genetics and
molecular biology in embryology and the study of birth defects, basic
genetic and molecular principles are discussed. llqe first chapter provides
an introduction to molecular processes, defines terms commonly used
in genetics and molecular biology, and describes key pathways used
2. CTO-DEFINITION
100% luminaldiameter obstruction without flow in that segment of 3 or more months duration
Presence of TIMI 0 flow within an occluded segment with an estimated occlusion duration of >/= to 3months
Eurointerven 2007 :30:43Heart 2012;98:822-828
A lesion with TIMI 0 flow within the occluded segment
that is judged to be at least 3 months in duration
3. Etiopathogenesis of CTO
1. The late organization and development after an acute occlusion.
2. The progressive occlusion of a long term and high-degree stenosis .
4. Mix of luminal plaque, thrombin,
fibrin, inflammatory cells,
neovascular channels, dense
collagen and calcium deposits.
Core composition correlates with
the CTO age.
Older occlusions- higher
fibrocalcific material (defined as
“hard plaques”)
CTOs -less than one year-less
fibrous materials (defined as “soft
plaque”)
5. No prospective randomized trial.
- In a meta-analysis of 13 observational trials encompassing 7288 pts over a 6 year
follow up ( Joyal D. et al 2010, Am Heart J ), successful recanalization was associated
with significant reduction in residual or recurrent angina. P<0.01).
- Improvement in all three health status domains of Seattle angina Questionarre.
( angina freq., physical limitation, and quality of life) – FACTOR TRIAL 2010.
- A considerable body of evidence suggests that ischemia is associated with adverse
CV events and the reduction of ischemic burden is associated with reduction in
mortality.
WHY TO OPEN UP A CTO ?
6. - In a large study of 10,627 pts undergoing adenosine SPECT, revascularization
compared with medical treatment had greater survival benefit ( absolute
and relative) in patients with inducible ischemia involving more than 10%
of ischemic myocardium (Hachamovitch et al . Circulation 2003)
- In COURAGE nuclear substudy, pts who achieved more than 5% reduction in
ischemic burden with PCI and OMT vs OMT alone had a lower unadjusted risk
of death or MI, particularly if they displayed moderate or severe ischemia
before treatment.
- 2011 ACCF/ AHA / SCAI , PCI of a CTO in patients with appropriate clinical
indications and suitable anatomy is reasonable when performed by operator
with appropriate expertise ( CLASS IIa, LOE B ).
8. J Am Coll Cardiol Intv. 2011;4(2):213-221. doi:10.1016/j.jcin.2010.09.024
J-CTO REGISTRY- (2006-2007),
498 PTS / 528 CTOs
Success rate – 88.6%
Retrograde used in 25.7% with 74.5%
success rate.
Coronary artery perforation- 13.6% in
collateral & 7.2% in CTO artery.
9. PROBABILITY OF ANTEROGRADE GUIDEWIRE
SUCCESS ( J-CTO REG.)
CTO SCORE
0
1
2
3
SUCCESS IN <30 MIN (%)
92.3
58.3
34.8
22.2
10. KEYS FOR SUCCESSFUL CTO RECANALIZATION
1. Proper preprocedure planning and angiographic detail.
2. Appropriate guide selection, ( EBU –LAD , AL 1 – LCX)
3. Appropriate wire selection
4. Judicious use of microcatheters
5. Proper selection of balloons,and other hardware(rotablation if required)
6. Most important is expertise of operator.
7. In japan registry(2002-2008), after introduction of new hardware and techniques, CTO-
PCI success rate is increased upto 90%. (compared to 50-70% in contemporary practice)
11. Preprocedure planning
Paramount importance
Spend time examining diagnostic films & decide on
Approach ,vascular access, guide shape & size
dedicated equipment availability
Occluded & contralateral vessel reviewed in multiple projection frame by frame to
understand complete anatomy
identify proximal & distal cap
vessel course & side branch
calcification
details of collateral circulation
Out of alignment of proximal & distal portion of occlusion with each beat is a sign
of tortuosity inside CTO
EURO CTO club;2012 consensus
12. Guide catheter selection
Percutaneous. Recanalization of Chronic Total Occlusion (CTO) Coronary Arteries: Looking Back and
Moving Forward
Simona Giubilato, Salvatore Davide Tomasello and Alfredo Ruggero Galassi
http://dx.doi.org/10.5772/54079
14. HOW TO INCREASE GUIDE SUPPORT
BEST OPTION FOR STRENGTHENING A GUIDE
1. FIRST best maneuver- put the guide in power position or
deep seat the guide.
2. SECOND best maneuver – Add a second stiffer wire
3. THIRD best maneuver – change to a stronger guide
4. use the balloon anchoring technique
5. insert a smaller straight inside the current guide(mother &
child)
6. remove everything- change the short sheath to a longer one
Advanced interventional cardiology TIPS AND TRICKS-
NGUYEN et al
15. Guide wires
Polymer coated wires – poor tactile feedback, lack of resistance
more chance of subintimal passage
Majority favor – step up approach – moderately increased stiffness(miracle-3)
– switch to greater stiffness &penetration ability, tapered (conquest pro wires)
Some believe –use of stiffer wires initially to cross hard occlusion cap
Rationale: risk of initial dissection minimized, procedure shortened &
simplified with this approach
Kcj 2010
Most common reason for failed CTO PCI- failure of GW to cross
Initial microchannel tracking - soft tapered polymer jacket wire
IVUS guided reentry from subintimal space to true lumen
Tapered High gram stiff wire
Soft polymer jacket wire(FIELDER XT) + microcatheter has improved chance of
antegrade recanalization in first attempt( EURO CTO REGISTRY)
24. ANTEROGRADE WIRING
1. A workhorse, spring coiled wire with a standard working bend is
loaded in an OTW or Micro-catheter.
2. The next wire to use is soft tipped, polymer jacketed, tapered wire
such as Fielder XT. This should be shaped with a 30- 45 degree bend at
1mm.
3. This wire should be manippulated in an attempt to dissect through
occlusion or cross a microchannel.
4. Next wire depends on anatomy :- If occlusion is short and straight-
heavy weight, high puncture force, CTO specific- Confianza pro/
Miracle series. If anatomy unclear or tortuous- Jacketed stiff tipped
such as PILOT 200.
5. Still not, dottering devices- Corsair , Tornus devices.
25. Low profile , trackable, OTW microcatheters - indispensable tool for CTO PCI
Allow ease of wire exchange
It ease torque in the tip response, preventing flexion, kinking, prolapse of
the guide wire, and improving penetration ability
Allows primary & secondary curve adjustment
Dedicated microcatheters – better tip flexibility > OTW balloons
Useful for CTO immediately distal to a bend
Larger inner lumen – reduces friction during wire manipulation
28. Available in 130cm and 150cm lengths, for the antegrade and retrograde approaches
respectively
29. Corsair – HYBRID (support & dilator)
Septal dilator catheter used for the
retrogradeapproach.
Dedicated for selective
engagement of the collateral
channel.
It consists of a tapered tip and
screw head structure, which
reinforces torque transmission for
the guide wire and creates better
back-up support for CTO
penetration.
The Corsair provides superior tip
flexibility which enables smooth
approaches to narrow tortuous
vessels, such as septal channels.
Corsair registry- 93 cto, retrograde, successful channel crossing 96.8%. Successful pci- 84%.
30. TORNUS
Developed to penetrate severe and
hard lesions with greater flexibility
and torquability with a rotational
burrowing advancement manually
manoeuvred by controlled counter-
clockwise rotation. (SCREWING
EFFECT). Platinum marker at the tip.
Useful in situation when wire
crossed the lesion but balloon could
not negotiate the lesion
32. Venture™ Catheter (Velocimed, Minneapolis, Minnesota, USA)- Tip
deflecting catheter, designed to help direct the wire where there are
difficult angles, at bends and in steering the wire away from dissection
planes.
Twin pass (Vascular Solutions, Inc Minneapolis, Minnesota, USA)- dual
access lumen rapid exchange micro-catheter (rapid exchange and over
the wire) which helps the guide wire placement and exchange after
reopening the occlusion and gaining access to different main branches.
Crusade (Kaneka Corporation, Japan- similar design and application of
the Twin pass
35. STRATEGIES FOR PCI OF CTO
DUAL WIRESINGLE WIRE
Soft tapered polymer
jacket wire
Middle weight spring coil
wire
High gram tapered wire
Parallel wire technique
Bilateral retrograde approach
IVUS guided approach
Yamane M Rev Esp Cardiol. 2012.
36. Procedural Steps of Current CTO-PCI
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 ,
N O . 9 , 2 0 1 1
S E P T E M B E R 2 0 1 1 : 9 4 1 – 5 1
38. Wire tip shaped as short as possible <45º
Second milder curve - improve maneuverability of wire
Exception - a sharp (>60º) angle with 1 to 2 mm bend based on lumen size, to
navigate the wire from subintimal space back to true lumen( Parallel wire
technique or IVUS guided wiring)
Confianza Pro or Pilot 200 - best suited to this purpose
EuroInterv.2006;2:375-381
How short tip can be bent – depends on length of soldering of spring coil at tip
Usually -1mm, fielder XT -<1mm
Korean Circ J 2010;40:209-215
39. Shaping the wire
1ºbend of 30-45º
1-2mm from tip
Find softest part
2ºbend-10-15º
@3-6mm
Work as a navigator
to orient tip
40. Tip curve should be just larger than lumen diameter
CTO, the lumen diameter = 0 mm
For CTO lesion - Guidewire-tip curve should be very small
Larger curve may hurt the vessel wall during direction control
Hermiller ,SCAI Fellows Course 2009
42. Different methods
Sliding AT proximal cap
Drilling inside CTO
Penetration Distal cap
Short, focal, straight noncalcified lesion – any method
Long tortuous calcified occlusion – wiring tailored to lesion
characteristics
Hard fibrocalcific plaque and tortuosity in CTO- major obstacle
watching the wire tip in relation to lumen in at least 2 orthogonal views
Yamane M Rev Esp Cardiol. 2012
HOW TO AVOID ENTERING THE INTIMA? When trying to cross a curved
segment, avoid positioning the wire at the outer curve of the bend.
3 fundamental elements of wire handling are ROTATING, PUSHING AND
PULLING the wire.
44. ideally there should not be side branches at the site of occlusion and point of entry
should be concave in shape
Simultaneous rotation & probing of lesion
High chance of entering to subintimal space ( tactile response - nil )
SLIDING
Relatively recent occlusion with predominance of microchannels
Extremly low friction wires for picking microchannels used
Recent total, subtotal occlusion ,ISR attempted with this strategy
Long duration – Microchannels replaced by fibrotic tissue
Indian Heart J. 2009; 61:275-280
45. BEWARE bridging collaterals masquerading as microchannel
Polymer sleeved wires NOT forced against resistance, small tip bend, probing with
mild rotation
Soft wires with polymer sleeve – Fielder series/ Whisper/ PT II
46. Drilling Strategy
If discrete entry point present
Technique
short curve(2mm) @45-60º to distal tip
sometimes a secondary curve given proximally
wire advanced with rapid rotational tip and gentle probing
start with MOD stiffness – progressive increase in stiffness(miracle)
Entry to false lumen judged by tactile feel on pulling stiff wire
Reserved for the most skilled and experienced operator
Ineffective with Blunt entry ,heavily calcific & resistant lesions
Indian Heart J. 2009; 61:275-280
48. Penetration
Technique
Pushing stiff wire slowly& gradually – minimum rotation to target direction
Tapered tip wires (confianza pro 9/12)
Softer tip intially progressively stiffer wires
Route determined – various angio or CT findings (not by tactile feel ).
Useful for blunt ,heavily calcific or resistant lesions
Not for CTO with tortuous angulated or bridging collaterals because of
higher chance of perforation
Drilling & penetration – guide support & tip load important
Tip load - success - chance of perforation
50. In the antegrade wire procedure,plaque tracking
should be described as either
1. intimal (loose tissue tarcking)
2. subintimal.
52. “Sigmoid Curve Sign” - to detect subintimal tracking .If the wire is running in a sigmoid
shaped curve with the same width as the vessel diameter, subintimal tracking should
be suspected
53. SENSATION FROM THE FINGERTIPS
.BODY
.GRASPED – false lumen tracking or high
resistance lesion
.SENSATION OF GETTING STUCK WHEN PULLING
BACK - in the intima
.RESISTANCE AT THE TIP OR MOVEMENT DECREASE
– in the false lumen
.EXIT
.FREE MOVEMENT – in the true lumen or in the
extravascular space.
Advanced interventional cardiology- NGUYEN et al
55. 1st wire in false channel
left in situ
2nd stiffer wire advanced parallel to first wire in same path
redirected to enter distal true lumen
main pitfall is wire twisting each other
Support catheter use, appropriate wire selection& handling –essential to avoid wire
twisting
Main purpose : - redirecting a wire inside body of a CTO & puncturing distal fibrous
cap
Important prerequisite – distal vessel visualization
Korean Circ J 2010;40:209-215
56. Visualization of 1st GW & its relative position to 2nd GW using orthogonal view is
essential for success of technique
Adopt the technique before a large subintimal dissection
Chance of successful recanalization by 2nd wire decreases proportionally to the
extent of sub-intimal dissection induced by the first guide-wire.
2nd wire –stiffer with superior torquability
Eg:Miracle12 or Conquest Pro 9/12
57. Check in multiple angiographic views
Advantages
a)Decreased fluro time
b) Reduced contrast
58. See-saw wiring technique
Modification of parallel wire technique
Uses 2 microcatheters or OTW baloons
When first wire fails , 2nd wire with microcatheter or OTW baloon is inserted
Risk – false lumen may enlarge – procedure failure
Japanese operators demonstrated ability to improve wire crossing over
time with this technique(Nakamura& Bae 2008)
59. IVUS Navigated Wiring
IVUS – Depict cross sectional view of coronary tree
IVUS focus on plaque distribution, calcification, reference vessel size & side
branch anatomy
Applicability of IVUS in CTO PCI
1)Side branch method to navigate CTO wire into true lumen from proximal cap .
helps in identify the ambiguous proximal cap.
2)Subintimal rentry from the proximal true lumen
IVUS guided sub intimal rentry – Last resort for getting a subintimal wire into
distal true lumen
Applicable even after losing site of distal vascular bed on angio
61. Importance of wire crossing from true lumen to true lumen
If Subintimal wire crosses without many side branch compromise
Subintimal stenting practical
CTO PCI should be planned to minimize subintimal wiring
Subintimal wiring & stenting – unavoidable in some
Eg: severe fibrocalcific occlusion over a negatively remodelled segment
Larger distal vascular bed – higher chance of TIMI-3 flow
62. WHEN BALLOON NOT
CROSSING CTO
- Deep seat the guide.
- Introduction of second wire into branch proximal to
occlusion to increase support of guide.
- Introduction of wire into true lumen adjacent to first wire
as buddy wire or to increase the dimensions of the channel.
- Larger and more supportive guides.
- Inflation of an angioplasty balloon either in MB or SB to
stabilize the guide.
- Debulking devices.
63. STAR Technique - Subintimal tracking and rentry technique
Used when attempts to recanalize true lumen failed.
0.014 hydrophillic wire with J configration used(whisper, pilot).
Hydrophillic wire pushed through subintimal dissection plane.
When pushed distal to occlusion, J tip should be directed to true lumen in an
attempt to reenter.
Successful in those with previous attempt failed.
Most Ideal vessel for STAR is RCA then LCx. And least ideal
is LAD. Not used now in view of frequent side branch compromise.
High chance of perforation.
Catheter Cardiovasc Interv 2005;64:407–411
Dissection reentry techniques
65. Knuckle wire technique
Polymer jacket wire (fielder XT or pilot-200)manipulated
to create wire loop – advanced subintimally-across CTO –
OTW system advanced to this area- rentry to true lumen
with a stiffer wire or pilot 200
66. BRIDGEPOINT RE-ENTRY SYSTEM
(FDA APPROVED)
CROSSBOSS CATHETER
FAST CTO- 149 pts, success -77% : 42 pts trial(japan)- 67% successful in previous failed cto-pci
68. WHEN TO STOP ANTEGRADE
• Creating a large false lumen.
• Disappearance of the distal vessel course(most likely
because collaterals were sheared off by dissection).
•Reaching limit of dye consumption( typically 600 ml in a
non-diabetic patient with normal renal function.)
•After 2 hours of unsuccessful wiring.(60 min of
flouroscopic time) NGUYEN: TIPS AND TRICKS 4th Ed.
•Excessive patient and operator fatigue.
71. •Initially used after a failed antegrade approach.
• Now used as initial strategy in challenging cases
1) Ostial occlusion 4) Large side branch at proximal cap
2) Long occlusion (>30mm) 5) Severe tortuosity and calcification
3) Without stump 6) Visible continuous collaterals
• Dual femoral arterial access preferred
72. Collateral selection
- Preference - Bypass graft > septal > epicardial
- Selective injection of collateral
- Wiring collateral – achieved with OTW system or dedicated
septal dialator(corsair)
- Contrast injection to assess best connection
- Before injection – aspirate to remove air in microcatheter
- Dripping saline over hub during insertion& removal of guidewire
73. - Hydrophillic polymer jacket wire with <1mm 30-45º tip used
to cross recipient artery
- Fielder FC, Pilot-50, Whisper, Choice PT, Runthrough
- Wiring done in diastole
- Wire should move freely - difficulty to advance – perforation?
- VPC or whipping of wire - RV or LV entry (rarely pericardium)
- Of no consequence if recognized before advancing OTW system
- Collateral dilatation using 1.25-1.5 mm balloon @ 1-2 atm or Corsair
- Epicardial collaterals
size most important factor in wiring success
should never be dilated
-Septal collaterals- tortuosity most imp. factor in wiring success
75. • Manipulation of both antegrade and retrograde wires in CTO until they meet
• Antegrade wire follow channel made by retrograde wire in true lumen of distal vessel
• Simplest form of retrograde technique
• Retrograde wire advanced to distal cap
Acts as a marker of distal true lumen
Serves as a target for antegrade wire
76. Most pure form of retrograde technique(only in 40% retro tech)
Hydrophillic wire advanced to the lesion
Advancement of microcatheter or OTW balloon – additional support
CTO crossed retrogradely using hydrophillic wire or stiffer wire
Manuevers to enhace chance of crossing:-
- Inflating retrograde balloon - coaxial anchor
- Stiffer tapered tip or hydrophillic wires
- IVUS facilitation of retrograde wire to proximal true lumen
77. Controlled antegrade & retrograde subintimal tracking
C A R T
Basic concept –create subintimal dissection with limited extension only at the site of
a CTO
Antegrade wire advanced into CTO then to subintimal space.
Retrograde wire through collateral with microcatheter to distal end of CTO -
into the CTO- then to subintimal space.
Balloon inflation inside CTO using small balloon over the retrograde wire to
subintima.
Balloon inflated inside CTO.
To keep inflated space open, deflated balloon left in subintimal space.
Surmely Jf et alnJ Invasive Cardiol 2006;18:334–338
Limited subintimal tracking (dissection) (LaST) only in CTO segment
79. Reverse CART technique
- Engage a guidewire retrogradely in the distal cap of the CTO
- Another wire anterogradely in the proximal cap of the CTO
- Retrograde wire advanced in subintimal space into CTO lesion
- Subintimal channel is enlarged by anterograde balloon
- Plaque dissection and modification of the lesion
- Retrograde wire advanced to cross the dissection
- Link up with the anterograde wire in proximal true lumen
- Wire externalized (Exchange length)
- Anterograde PCI done
81. KNUCKLE WIRE TECHNIQUE
Best suited for long segment of occlusion
Retrograde wire usually a polymer jacket wire manipulated to form a loop at wire
tip advanced in subintimal space across CTO
Eg: Fielder XT or Pilot-200
Rounded wire loop advanced in subintimal space across CTO without causing
perforation
OTW system advanced to this area followed by attempt to reenter
true lumen using a stiffwire with short bend or hydrophillic wire
Eg: Confianza Pro 12 or Pilot 200
82. Treating lesion after crossing
1 . CTO crossed by antegrade wiring (kissing wire, just marker, CART)
Antegrade CTO PCI can be done
Retrograde balloon can trap antegrade wire to facilitate procedure
2 . Retrograde wire crosses to true lumen
Options : Antegrade wiring
Retrograde wire externalization
ACROSTAK ACROSS CTO BALLOON - smallest lesion entry profile(0.015”), 1.1 mm
DES is preferred in CTO PCI
Viper advance wire preffered for retrograde wire externalisation
83. Complications
Thrombosis and dissection of donor artery
Collateral perforation & occlusion
treated with coil embolization
injection of autologous subcutaneous fat tissue/thrombus
emergency CABG
Entrapment of pci equipment in septal collaterals
Radiation skin injury/CIN/
Subintimal stenting – late coronary aneurysm & stent fractures
85. SafeCross RF Guidewire System
The Safe-Cross radiofrequency guidewire
(IntraLuminal Therapeutics, Carlsbad,
California) combines 3 capabilities: (1)
steerability of a conventional 0.014-in
intermediate-stiffness guidewire, (2) optical
coherence reflectometry to warn the operator
when the wire tip approaches within 1 mm of
the vessel wall, and (3) delivery of
radiofrequency energy pulses to the wire tip
to facilitate passage through an occluded
segment.
NOW FDA APPROVED FOR CORONARY CTO
87. special role in refractory in-stent CTOs wherein the stent serves to
confine the device as it passes through the occlusion
FDA APPROVED for coronary CTO.
Success rate of 56% in series of 107 pts with previous failed cto pci. Perforation rate 0.9-6%
90. UNDER EVALUATION
- Prolonged infusions of fibrinolytic agents
- Collagenase infusion
- ultrasound device(CROSSER, FlowCardia, Inc)- therapeutic ultrasound in
crossing vascular occlusions
- Vibrational angioplasty (Medical Miracles) is a mechanical device that
generates reciprocal and lateral movements in the distal end of a standard
guidewire with frequencies of 16 to 100 Hz
- Ultrasoundguided Pioneer catheter (Medtronic AVE)- Lumen reentry devices
- An alternative approach to CTOs with the use of the Pioneer system also
undergoing investigation is the creation of connections between a coronary
artery and vein (percutaneous in situ coronary vein arterialization [PICVA])
- novel guidance modalities are under development, including forward-looking
ultrasound69,70 and magnetically enabled 3-dimensional wire guidance
94. COMPATIBILITY OF DEVICES INSIDE A 6 FR GUIDING CATHETER.
A) COMBINATION OF FINECROSS AND MONORAIL BALLOON;
B) COMBINATION OF TWO FINECROSS MICROCATHETERS; C)
COMBINATION OF VALET AND MONORAIL BALLOON; D)
COMBINATION OF VALET AND FINECROSS.
95. COMPATIBILITY OF DEVICES INSIDE AN 8 FR GUIDING CATHETER. A)
COMBINATION OF STINGRAY® (BRIDGEPOINT/BOSTON SCIENTIFIC,
NATICK, MA, USA) AND 1.25 MM OTW BALLOON; B) COMBINATION OF
TWO CORSAIRS AND A MONORAIL BALLOON; C) COMBINATION OF TWO
CORSAIRS AND IVUS PROBE; D) COMBINATION OF VENTURE AND
CORSAIR PLUS IVUS PROBE.